6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 1g

5-(BENZYLOXY)-2-METHYLPHENOL, 95.0%, 250mg

5-Bromo-4-methylpyrimidine, 95.0%, 1g

(3R,4R)-3-methyl-4-(trifluoromethyl)pyrrolidine hydrochloride, 98%, 1g

6-Bromonicotinic acid ethyl ester, 95.0%, 100g

3-Bromo-n-methyl-5-nitropyridin-4-amine, 95+%, 100mg

3-Iodo-9-phenylcarbazole>98.0%(GC)1g

2-(BENZOFURAN-5-YL)ETHANOL, 95.0%, 250mg

8-CHLOROQUINOLIN-2-AMINE, 95.0%, 1g

Biocular iScope IS.1152-EPLi con objetivos E-plan IOS y mesa cruzada sin bastidor (infinito)

7-[5-[[4-[4-[(Dimethylamino)sulfonyl]-1-piperazinyl]phenoxy]methyl]-1,3-dimethyl-1H-pyrazol-4-yl]-1-[2-(4-morpholinyl)ethyl]-3-[3-(1-naphthalenyloxy)propyl]-1H-indole-2-carboxylic acid, 98%, 250mg

(R)-1-(2-Bromo-5-chlorophenyl)ethan-1-amine hydrochloride, 100mg

2,5-dichloro-3,6-dimethylpyrazine, 95.0%, 5g